Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2021 Nov;25(11):1215-1223.
doi: 10.1007/s10157-021-02094-9. Epub 2021 Jun 15.

Impact of polypharmacy on all-cause mortality and hospitalization in incident hemodialysis patients: a cohort study

Tatsunori Toida  1   2 , Reiko Toida  3 , Risa Takahashi  4 , Shigehiro Uezono  3 , Hiroyuki Komatsu  5 , Yuji Sato  6 , Shouichi Fujimoto  7
Affiliations
Observational Study

Impact of polypharmacy on all-cause mortality and hospitalization in incident hemodialysis patients: a cohort study

Tatsunori Toida et al. Clin Exp Nephrol. 2021 Nov.

Abstract

Background: Polypharmacy (PP) is common in end-stage chronic renal disease patients largely due to the presence of multiple comorbid conditions. Although PP is potentially harmful, its relationship with mortality and morbidity in hemodialysis patients currently remains unclear.

Methods: Study design: cohort study.

Setting: participants: one hundred and fifty-two initial hemodialysis patients (male, 88 patients; mean age, 70.3 years) were enrolled between February 2015 and March 2018 at Nobeoka Prefectural Hospital and Chiyoda Hospital.

Predictor: patients were divided into 2 groups according to PP (6 or more drug prescriptions or less) during admission and discharge for the initiation of hemodialysis.

Outcomes: all-cause mortality and hospitalization during the mean 2.8-year follow-up.

Measurements: hazard ratios (HRs) were estimated using Cox's model for the relationships between PP and clinical outcomes and adjusted for potential confounders. The group with 5 or less drug prescriptions was set as a reference.

Results: The number of prescribed drugs per patient averaged 7.4 at admission and 7.0 at discharge for initial hemodialysis. One hundred (65.8%) and 94 patients (61.8%) had PP at admission and discharge, respectively. During the follow-up, 20 patients died and 71 were hospitalized. PP at admission did not correlate with outcomes, whereas that at discharge correlated with all-cause hospitalization.

Conclusions: PP at discharge may be associated with clinical outcomes. However, it remains unclear whether PP is the direct cause of outcomes or is simply a marker for an increased risk of outcomes.

Keywords: All-cause mortality; Hemodialysis; Hospitalization; Polypharmacy.

PubMed Disclaimer

References

    1. Mills EJ, Rachlis B, Wu P, Devereaux PJ, Arora P, Perri D. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients. J Am Coll Cardiol. 2008;52(22):1769–81. - PubMed - DOI - PMC
    1. Peterson C, Gustafsson M. Characterisation of drug-related problems and associated factors at a clinical pharmacist service-naïve hospital in Northern Sweden. Drugs Real World Outcomes. 2017;4(2):97–107. - PubMed - PMC - DOI
    1. Blix HS, Viktil KK, Reikvam Å, Moger TA, Hjemaas BJ, Pretsch P, et al. The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals. Eur J Clin Pharmacol. 2004;60(9):651–8. - PubMed - DOI - PMC
    1. Lisby M, Nielsen LP, Mainz J. Errors in the medication process: frequency, type, and potential clinical consequences. Int J Qual Heal Care. 2005;17(1):15–22. - DOI
    1. Smedberg J, Bråthen M, Waka MS, Jacobsen AF, Gjerdalen G, Nordeng H. Medication use and drug-related problems among women at maternity wards—a cross-sectional study from two Norwegian hospitals. Eur J Clin Pharmacol. 2016;72(7):849–57. - PubMed - DOI - PMC

Publication types

LinkOut - more resources